Development of vaccines for SARS-CoV-2
- PMID: 32850116
- PMCID: PMC7431966
- DOI: 10.12688/f1000research.25998.1
Development of vaccines for SARS-CoV-2
Abstract
COVID-19 emerged in late 2019 and has rapidly spread through many countries globally. The causative SARS-CoV-2 virus was not known until recently, and there is little or no natural immunity in human populations. There is an urgent need for vaccines and drugs to combat this new pandemic. In just a few months, huge efforts and resources by government, academia, and industry have been thrown into the race to develop a vaccine. This brief review summarizes and discusses the array of technologies being applied to vaccine development, highlighting the strengths and weaknesses of the various approaches.
Keywords: COVID-19; SARS-CoV-2; Vaccines.
Copyright: © 2020 Ng WH et al.
Conflict of interest statement
No competing interests were disclosed.No competing interests were disclosed.No competing interests were disclosed.
Similar articles
-
SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines.J Transl Med. 2020 Jun 3;18(1):222. doi: 10.1186/s12967-020-02392-y. J Transl Med. 2020. PMID: 32493510 Free PMC article.
-
Status of COVID-19 vaccine development.Tidsskr Nor Laegeforen. 2020 Sep 9;140(13). doi: 10.4045/tidsskr.20.0676. Print 2020 Sep 29. Tidsskr Nor Laegeforen. 2020. PMID: 32998488 English, Norwegian.
-
Vaccine designers take first shots at COVID-19.Science. 2020 Apr 3;368(6486):14-16. doi: 10.1126/science.368.6486.14. Science. 2020. PMID: 32241928 No abstract available.
-
Current development of COVID-19 diagnostics, vaccines and therapeutics.Microbes Infect. 2020 Jul-Aug;22(6-7):231-235. doi: 10.1016/j.micinf.2020.05.001. Epub 2020 May 6. Microbes Infect. 2020. PMID: 32387332 Free PMC article. Review.
-
Consensus summary report for CEPI/BC March 12-13, 2020 meeting: Assessment of risk of disease enhancement with COVID-19 vaccines.Vaccine. 2020 Jun 26;38(31):4783-4791. doi: 10.1016/j.vaccine.2020.05.064. Epub 2020 May 25. Vaccine. 2020. PMID: 32507409 Free PMC article.
Cited by
-
Recent Advances in Pathophysiology, Drug Development and Future Perspectives of SARS-CoV-2.Front Cell Dev Biol. 2020 Nov 6;8:580202. doi: 10.3389/fcell.2020.580202. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33240881 Free PMC article. Review.
-
How a Novel Approach of Allergy Call Center Improved the Management of the Anti-COVID Vaccination Campaign in Piedmont: Italy.J Epidemiol Glob Health. 2024 Dec;14(4):1764-1770. doi: 10.1007/s44197-024-00309-2. Epub 2024 Oct 14. J Epidemiol Glob Health. 2024. PMID: 39400652 Free PMC article.
-
Various theranostics and immunization strategies based on nanotechnology against Covid-19 pandemic: An interdisciplinary view.Life Sci. 2021 Aug 1;278:119580. doi: 10.1016/j.lfs.2021.119580. Epub 2021 May 12. Life Sci. 2021. PMID: 33991549 Free PMC article. Review.
-
Review on Up-to-Date Status of Candidate Vaccines for COVID-19 Disease.Infect Drug Resist. 2021 Jan 19;14:151-161. doi: 10.2147/IDR.S288877. eCollection 2021. Infect Drug Resist. 2021. PMID: 33500636 Free PMC article. Review.
-
Exploring the Relation Between Health Literacy, Infodemic, and Acceptance of COVID-19 Vaccination in Iran: A Cross-Sectional Study.Health Lit Res Pract. 2024 Oct;8(4):e184-e193. doi: 10.3928/24748307-20240607-01. Epub 2024 Oct 8. Health Lit Res Pract. 2024. PMID: 39378074 Free PMC article.
References
-
- Coronavirus disease (COVID-2019) situation reports. WHO.2020. Reference Source
-
- WHO Director-General's opening remarks at the media briefing on COVID-19 - 13 March 2020. WHO.2020. Reference Source
-
- Cohen J: With record-setting speed, vaccinemakers take their first shots at the new coronavirus. Science. 2020. Reference Source
-
- Draft landscape of Covid-19 candidate vaccines. World Health Organization.2020; [cited 2020 6 July]. Reference Source
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous